Clinical Trials on Chanarin-Dorfman Syndrome

Total 7 results





    • NCT02918032
      Recruiting
      Conditions: Neutral Lipid Storage Disease
    • NCT02830763
      Terminated
      Conditions: Primary Triglyceride Deposit Cardiomyovasculopathy (TGCV); Neutral Lipid Storage Disease With Myopathy (NLSD-M)
    • NCT02635269
      Active, not recruiting
      Conditions: Metabolism, Inborn Errors; Lipid Metabolism, Inborn Errors; Carbohydrate Metabolism, Inborn Errors; Long-Chain 3-Hydroxyacyl-CoA Dehydrogenase Deficiency; Glycogenin-1 Deficiency (Glycogen Storage Disease Type XV); Carnitine Palmitoyl Transferase 2 Deficiency; VLCAD Deficiency; Medium-chain Acyl-CoA Dehydrogenase Deficiency; Multiple Acyl-CoA Dehydrogenase Deficiency; Carnitine Transporter Deficiency; Neutral Lipid Storage Disease; Glycogen Storage Disease Type II; Glycogen Storage Disease Type III; Glycogen Storage Disease Type IV; Glycogen Storage Disease Type V; Muscle Phosphofructokinase Deficiency; Phosphoglucomutase 1 Deficiency; Phosphoglycerate Mutase Deficiency; Phosphoglycerate Kinase Deficiency; Phosphorylase Kinase Deficiency; Beta Enolase Deficiency; Lactate Dehydrogenase Deficiency; Glycogen Synthase Deficiency
    • NCT02193867
      Terminated
      Conditions: Lysosomal Acid Lipase Deficiency
    • NCT01527318
      Completed
      Conditions: Neutral Lipid Storage Disease
    • NCT01473875
      Terminated
      Conditions: Lysosomal Acid Lipase Deficiency; Wolman Disease
    • NCT01371825
      Completed
      Conditions: Lysosomal Acid Lipase Deficiency; Wolman Disease